Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies-Reference-Cited by-同舟云学术

Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies

Published:2016-07-14 Issue:1 Volume:1 Page:
ISSN:2470-9468
Container-title:Science Immunology
language:en
Short-container-title:Sci. Immunol.

Author:

Moody M. Anthony¹²³,Pedroza-Pacheco Isabela⁴,Vandergrift Nathan A.¹⁵,Chui Cecilia⁴,Lloyd Krissey E.¹,Parks Robert¹,Soderberg Kelly A.¹,Ogbe Ane T.⁴,Cohen Myron S.⁶,Liao Hua-Xin¹⁵,Gao Feng¹⁵,McMichael Andrew J.⁴,Montefiori David C.⁷,Verkoczy Laurent¹⁵⁸,Kelsoe Garnett¹²,Huang Jinghe⁹,Shea Patrick R.¹⁰,Connors Mark⁹,Borrow Persephone⁴,Haynes Barton F.¹²⁵

Affiliation:

1. Duke University Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.

2. Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA.

3. Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA.

4. Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, UK.

5. Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.

6. University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

7. Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA.

8. Department of Pathology, Duke University School of Medicine, Durham, NC 27710, USA.

9. Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20814, USA.

10. Institute for Genomic Medicine, Columbia University, New York, NY 10032, USA.

Abstract

Individuals infected with HIV-1 who produce broadly neutralizing antibodies have a distinct immunological landscape.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine,Immunology

Reference111 articles.

1. Ending AIDS — Is an HIV Vaccine Necessary?

2. HIV-1 neutralizing antibodies: understanding nature's pathways

3. Antibody responses to envelope glycoproteins in HIV-1 infection

4. Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

5. Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mRNA-based HIV-1 vaccines;Clinical Microbiology Reviews;2024-09-12

2. Research on Maternal Vaccination for HIV Prevention;Clinics in Perinatology;2024-09

3. Neutralization activity in chronic HIV infection is characterized by a distinct programming of follicular helper CD4 T cells;2024-08-03

4. The CH1 domain influences the expression and antigen sensing of the HIV-specific CH31 IgM-BCR and IgG-BCR;Proceedings of the National Academy of Sciences;2024-07-23

5. ATP-P2X7R pathway activation limits the Tfh cell compartment during pediatric RSV infection;Frontiers in Immunology;2024-07-09